INTRODUCTION {#sec1}
============

Chronic respiratory diseases are a prominent cause of morbidity and mortality worldwide ([@B5]), with chronic obstructive pulmonary disease (COPD) being the third leading cause of death in the United States. Chronic lung diseases, such as COPD and idiopathic pulmonary fibrosis (IPF), are characterized by extensive changes in the extracellular matrix (ECM), the three-dimensional (3D) scaffold that provides mechanical and biochemical support/signals to cells. The ECM is often an underrecognized element in lung disease ([@B4], [@B13], [@B29]). However, increasing evidence suggests that the ECM plays an active role in lung pathophysiology.

Mechanical properties of the ECM dictate, in part, cellular responses to injury, with stiffness being explored most commonly ([@B3], [@B14], [@B19]). The lung ECM is a viscoelastic network of both elastic and nonelastic constructive fibrillar proteins embedded in a water-retaining gel of proteoglycans and glycosaminoglycans. Viscoelastic materials exhibit time-dependent strain often measured as relaxation when undergoing deformation ([@B6]). Viscoelasticity as a mechanical property influences cellular spreading, proliferation, and differentiation, together with or independently of stiffness ([@B7], [@B8]). For the lung, which undergoes repeated stretch and relaxation, usually greater than 14,000 times each day, replicating the mechanical properties of the ECM is essential to accurately model the cellular environment in vitro.

Synthetic hydrogels have found their way into tissue engineering as ECM mimics. Natural hydrogels have been generated from, e.g. decellularized human adipose ([@B20]), heart ([@B15]), and liver ([@B17]) tissue and more ([@B1], [@B9], [@B23], [@B25]). As for the lung, hydrogels have been generated from porcine lung ECM ([@B22]). ECM hydrogels are generated from intact tissue by detergent-based decellularization then gentle proteolytic solubilization (often with pepsin). Upon pH neutralization and bringing to physiological osmolarity, hydrogels form spontaneously at 37°C. As such, these hydrogels comprise the native ECM composition, albeit not the macroscopic (micrometer sized) architecture ([@B10], [@B23]).

In this study we report for the first time the generation of ECM hydrogels from control and diseased \[COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) IV and IPF\] human lung tissues. The mechanical features of these human lung ECM hydrogels as well as intact human lung stiffness and viscoelasticity were measured. Our data indicate that the ECM hydrogels partially replicate the mechanical properties of human lung tissue.

MATERIALS AND METHODS {#sec2}
=====================

 {#sec2-1}

### Processing of human lung tissue. {#sec2-1-1}

Tissue from human explanted lungs was obtained through the Department of Pathology, remaining after diagnostic procedures from control (nonusable donor lungs and tumor resection material; *n* = 13) and COPD GOLD IV (*n* = 15) or IPF (*n* = 12) patients undergoing lung transplantation or lung resection in the University Medical Center Groningen. The protocol was consistent with the Research Code of the UMCG and national ethical and professional guidelines ("Code of conduct; Dutch federation of biomedical scientific societies," <https://www.federa.org> and <https://www.umcg.nl/SiteCollectionDocuments/English/Researchcode/umcg-researchcode-2018-nl.pdf>). Deidentified control and IPF human lung tissue were provided by the University of Michigan; as the tissues were deidentified and coming from deceased donors, the University of Michigan Institutional Review Board deemed this work exempt from oversight.

### Decellularization of human lung tissue. {#sec2-1-2}

Lung tissues (control *n* = 3, COPD GOLD IV *n* = 10, or IPF *n* = 3) were minced with a blender, washed with demineralized H~2~O (dH~2~O), treated with trypsin (0.05% final concentration; Thermo Fisher Scientific, Waltham, MA), and incubated (37°C, 3 h) ([Fig. 1*A*](#F0001){ref-type="fig"}). The homogenate was repeatedly washed with dH~2~O until the supernatant remained clear before being sequentially treated with saturated NaCl (6 M) solution, 70% ethanol, 1% SDS solution, 1% Triton X-100, 1% sodium deoxycholate, and 30 µg/mL DNase (in 1.3 mM MgSO~4~ and 2 mM CaCl~2~) solution, with three washes with dH~2~O between treatments, each for 24 h at room temperature (RT) with constant shaking, except for the enzymatic treatments, which were at 37°C with shaking. The resultant decellularized ECM (dECM) was stored in sterile PBS containing 1% penicillin-streptomycin at 4°C. Decellularized tissues ([@B3]) were provided by the University of Michigan (control *n* = 6, IPF *n* = 6).

![Hydrogel generation and mechanical characterization. *A*: overview of the decellularization process used for human lung. *B*: the solubilization and gelation process of decellularized human lung. *C*: low-load compression testing measuring stiffness and viscoelastic properties. Samples were compressed by 20% measuring stiffness, after which the stress relaxation was monitored as a function of time (*t*). Stress relaxation was modeled with a generalized Maxwell model with 3--4 elements (*E*). η = Viscosity (mPa·s). dP = change in pressure due to compression.](zh50042077930001){#F0001}

### Generating lung dECM hydrogels. {#sec2-1-3}

The dECM samples were snap frozen in liquid nitrogen and lyophilized with a FreeZone Plus lyophilizer (Labconco, Kansas City, MO) and then ground to a powder with an ULTRA-TURRAX (IKA, Staufen, Germany). dECM samples from different donors from the same disease group (control *n* = 9, COPD GOLD IV *n* = 10, or IPF *n* = 9) were pooled. The lung dECM powder (20 mg/mL) was digested with 2 mg/mL porcine pepsin (Sigma-Aldrich, St. Louis, MO; [Fig. 1*B*](#F0001){ref-type="fig"}) in 0.01 M HCl with constant agitation at RT for 72 h. The digest was centrifuged at 500 *g* for 3 min to remove any remaining undigested insoluble aggregates. The pH was neutralized with 0.1 M NaOH and brought to 1× PBS with one-tenth volume 10× PBS: this generated the pre-gel. Human lung ECM hydrogels were prepared in 48-well plates with 300 µL of pre-gel per well at 37°C for 1 h. Lung ECM gels were covered with 500 µL of Hanks' balanced salt solution (Lonza, Verviers, Belgium) to prevent desiccation before mechanical testing. Sections of lung ECM hydrogels were stained with hematoxylin and eosin (H&E) ([@B12]); images were captured with a slide scanner (Nanozoomer 2.0 HT; Hamamatsu Photonics).

### Protein distribution of whole, decellularized, and pepsin-digested lung tissue. {#sec2-1-4}

The protein content of native lung tissue, dECM powder, and pepsin-digested dECM (pre-gel) was examined. Twenty milligrams of whole tissue and dECM powder was solubilized in 1 mL of RIPA buffer (Thermo Fisher Scientific, Waltham, MA) containing 4 µL of proteinase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and 10 µL of phosphatase inhibitor cocktail (Thermo Fisher Scientific, Waltham, MA), and 20 mg of pre-gel was prepared. The solubilized tissue, dECM powder, and pepsin-digested ECM solution were mixed 1:1 with 2× sample buffer and separated on 5% and 10% SDS-PAGE gels. The gels were stained with Coomassie brilliant blue for 1 h and destained with 50% methanol, 10% acetic acid. Images of the stained gels were subsequently digitized.

### Mechanical properties. {#sec2-1-5}

Fresh tissue (control *n* = 4, COPD GOLD IV *n* = 5, or IPF *n* = 3) and lung dECM hydrogels from control, COPD GOLD IV, and IPF were subjected to stress relaxation testing with a low-load compression tester (LLCT) at RT ([Fig. 1*C*](#F0001){ref-type="fig"}), as described previously ([@B24]). The LabVIEW 7.1 program was used for the LLCT load cell and linear positioning for control and data acquisition. The resolution in position, load, and time determination was 0.1 mm, 2 mg, and 25 ms, respectively, and the velocity of motion was controlled in feedback mode. The top plate moved downward (5 µm/s) until it experienced a counterforce of 10^−4^ N. Samples were deformed by 20% of their original thickness (strain ε = 0.2) at a deformation speed of 20%/s (strain rate ε̇ = 0.2 s^−1^). The diameter of the indentation probe was 2.5 mm. The deformation was held constant for 200 s and the required stress monitored. During compression, the required stress was plotted against the strain. In this plot, a linear increase in stress as a function of strain was observed between a strain of 0.04 and 0.1; the slope of the line fit to this region was taken as stiffness (Young's modulus). Since the stiffness of the viscoelastic gel depends on the strain rate, values reported here are valid only at a strain rate of 0.2 s^−1^.

Stress relaxation, the required stress to maintain a constant strain of 0.2, continuously decreases with time, which is a clear indication of the viscoelastic nature of materials. The shape of the stress relaxation curve was mathematically modeled with a generalized Maxwell model ([@B2]) ([Fig. 1*C*](#F0001){ref-type="fig"}). The continuously changing stress \[σ(*t*)\] was converted into continuously changing stiffness \[*E*(*t*)\] by dividing with the constant strain of 0.2. *E*(*t*) was fitted to [*Eq. 1*](#E1){ref-type="disp-formula"} to obtain the relaxation time constants (τ), and [*Eq. 2*](#E2){ref-type="disp-formula"} provided relative importance (R~i~) for each Maxwell element.$$E\text{(}t\text{)} = E_{1}e^{\frac{t}{\text{τ}_{1}}} + E_{2}e^{\frac{t}{\text{τ}_{2}}} + E_{3}e^{\frac{t}{\text{τ}_{3}}} + E_{4}e^{\frac{t}{\text{τ}_{4}}}$$$$\text{R}_{\text{i}} = \frac{E_{i}}{E_{1} + E_{2} + E_{3} + E_{4}}$$where *i* varies from 1 to 4 or from 1 to 3 when necessary. The optimal number of Maxwell elements was determined with the chi-square function expressed by [*Eq. 3*](#E3){ref-type="disp-formula"} (typically 3 or 4) and visually matching the modeled stress relaxation curve to the measured curve ([Fig. 1*C*](#F0001){ref-type="fig"}).$$\text{χ}^{2} = {\sum_{j = 0}^{200}\left\lbrack \frac{E_{j} - E\left\lbrack t_{j} \right\rbrack}{\text{σ}_{j}} \right\rbrack}$$where *j* varies from 0 to 200 s, *E~j~* is the experimentally measured value at time *j*, *E*(*t~j~*) is the fit values at time *j* calculated with [*Eq. 1*](#E1){ref-type="disp-formula"}, and σ*~j~* is the standard error that the LLCT makes because of inherent errors in position, time, and load measurements.

### Statistical analyses. {#sec2-1-6}

Mechanical characterization measurements were obtained from three locations per tissue piece, and for each hydrogel four replicate gels were made and measured on three separate occasions. Data are expressed as median and standard deviation (SD). Statistical analyzes were performed with Prism 7 software (GraphPad, San Diego, CA). Differences between tissue and corresponding ECM hydrogels were tested by Mann--Whitney *U* test and considered significant when *P* \< 0.05.

RESULTS {#sec3}
=======

 {#sec3-1}

### Protein distribution of whole, decellularized, and pepsin-digested lung tissue. {#sec3-1-1}

The banding pattern did not differ between control, COPD GOLD IV, and IPF whole tissue ([Fig. 2*A*](#F0002){ref-type="fig"}). Decellularized IPF powder had the highest protein content, whereas decellularized control and COPD GOLD IV protein contents were hardly detectable by Coomassie staining. The banding pattern for pepsin-digested dECM was similar for all tissue types.

![Extracellular matrix (ECM) hydrogel protein distribution and fiber organization. *A*: protein distribution in intact tissue, decellularized ECM (dECM) powder, and pepsin-digested dECM (pre-gel) for control, chronic obstructive pulmonary disease (COPD) Global Initiative for Chronic Obstructive Lung Disease (GOLD) IV, and idiopathic pulmonary fibrosis (IPF) on a 5% and 10% SDS-PAGE gel stained with Coomassie brilliant blue. *B*: hematoxylin and eosin (H&E)-stained sections of control, COPD GOLD IV, and IPF dECM hydrogels at ×10 and ×20 magnification showing the fiber organization within the ECM hydrogels. Brightness/contrast was adjusted equally for visual presentation of all H&E images.](zh50042077930002){#F0002}

### Generation of human lung ECM hydrogels. {#sec3-1-2}

Pepsin digestion times were varied from 8 to 72 h (data not shown), and after 72 h of digestion, with the addition of NaOH and 10× PBS, a stable hydrogel was generated from control, COPD GOLD IV, and IPF pepsin-digested dECM.

### Human lung ECM hydrogel fiber organization. {#sec3-1-3}

H&E staining showed a difference in fiber organization between the ECM hydrogels ([Fig. 2*B*](#F0002){ref-type="fig"}). The IPF ECM hydrogel fibers appeared to form a dense network structure, whereas control and COPD GOLD IV ECM hydrogels formed more open, loose structures.

### Stiffness of ECM hydrogels resembles native tissue. {#sec3-1-4}

The stiffness of lung tissue displayed a degree of heterogeneity ([Fig. 3*A*](#F0003){ref-type="fig"}), which was most apparent in IPF tissue, ranging from 9 kPa to 38.5 kPa. Average IPF tissue stiffness (18.9 ± 11.1 kPa) was higher than both control (3.7 ± 1.3 kPa) (*P* \< 0.05) and COPD GOLD IV (2.9 ± 0.8 kPa) (*P* \< 0.05) lung tissue. dECM hydrogel stiffness followed a similar pattern, with average IPF dECM hydrogel stiffness (6.8 ± 2.8 kPa) also being greater than control (1.1 ± 0.2 kPa) (*P* \< 0.05) and COPD GOLD IV (1.5 ± 0.4 kPa) (*P* \< 0.05). Each dECM hydrogel had a reduced stiffness compared with its intact tissue counterpart (*P* \< 0.05).

![Stiffness and viscoelasticity of lung tissue and extracellular matrix (ECM) hydrogels. *A*: the stiffness of native lung tissue and corresponding ECM hydrogels. COPD GOLD IV, chronic obstructive pulmonary disease Global Initiative for Chronic Obstructive Lung Disease IV; IPF, idiopathic pulmonary fibrosis. *B*: total relaxation of the compressive force applied at 20% deformation over 200 s. *C*: Maxwell element relaxation time constants. *D*: the contribution (relative importance) of each Maxwell element to the total relaxation. Measurements were obtained from 3 locations per tissue piece (control *n* = 5, COPD GOLD IV *n* = 5, and IPF *n* = 3), and for each hydrogel 4 replicate gels were made and measured individually on 3 separate occasions. Mann--Whitney *U* test comparing tissue and hydrogel: \**P* \< 0.005.](zh50042077930003){#F0003}

### Total relaxation of ECM hydrogels does not mimic native tissue. {#sec3-1-5}

After initial compression of 20%, the dissipation of the force was monitored over 200 s ([Fig. 3*B*](#F0003){ref-type="fig"}). The total stress relaxation of IPF lung tissue was lower (72.1 ± 13.1 kPa) than control lung tissue (88.7 ± 10.4 kPa) (*P* \< 0.05), which was similar to relaxation of COPD GOLD IV (87.0 ± 7.9 kPa). The total relaxation percentage was 100% for all hydrogels except for IPF lung dECM hydrogels (99.3 ± 0.8%). The total relaxation for all dECM hydrogels was higher (*P* \< 0.05) than that of all corresponding lung tissues.

### Maxwell element relaxation time constants similar between hydrogels and tissue. {#sec3-1-6}

The relaxation time constants (τ) of all elements for tissue were longer than those of dECM hydrogels (*P* \< 0.05) ([Fig. 3*C*](#F0003){ref-type="fig"}). All lung tissues and IPF dECM hydrogels required 4 Maxwell elements to describe the total relaxation seen in [Fig. 3*B*](#F0003){ref-type="fig"}, whereas control and COPD GOLD IV dECM hydrogels needed only 3 elements. The τ of control tissue Maxwell lasted longer than control ECM gels (and required 1 additional element). COPD GOLD IV tissue also required 1 additional element, and each individual element lasted longer than the equivalent element in COPD GOLD IV dECM hydrogel. Finally, IPF tissue and IPF dECM hydrogel both were described by 4 elements, with the IPF tissue elements lasting longer.

### Maxwell elements' relative importance to relaxation of ECM hydrogels and tissue. {#sec3-1-7}

The R~i~ of the 4th Maxwell element described the largest proportion of the relaxation in native lung tissues (control 28.7%, COPD GOLD IV 31.2%), but especially in IPF tissue (44.6%) ([Fig. 3*D*](#F0003){ref-type="fig"}). In contrast, the R~i~ of the 1st Maxwell element contributed the most to the relaxation in the dECM hydrogels from all groups (44.6% for control, 44.8% for COPD GOLD IV, and 49.7% for IPF). Within the IPF dECM hydrogels, a 4th element with a low R~i~ (10.5%) also contributed to the relaxation. The 2nd and 3rd element contributions were higher in all hydrogels compared with tissue (*P* \< 0.05), with the exception of the contribution of the 3rd element in IPF tissue and hydrogel, which did not differ.

DISCUSSION {#sec4}
==========

This study shows, for the first time, that human lung tissue can be decellularized, reduced to a powder, and reconstituted as a hydrogel. Furthermore, this can be accomplished with control, COPD GOLD IV, and IPF lung tissues, generating a 3D hydrogel that reflects the stiffness of native tissue.

The protein contents detected by SDS-PAGE in native lung tissue, decellularized lung, and pepsin-digested lung dECM were consistent, with the exception of the dECM IPF, which was greater. The native tissues contained total cellular and extracellular components, and given the equal loading of protein, the expected similarity in protein banding patterns was observed between control, COPD GOLD IV, and IPF. Of the different dECM powders IPF yielded the highest protein content; however, it was not clear if this reflected a difference in protein yield or differential solubilization with RIPA buffer that may have been favorable to the proteins abundant in IPF tissue. Favorably, the protein yield and banding distribution after pepsin digestion were similar between the different groups.

The 72 h pepsin digestion required for generating human lung dECM hydrogels was substantially longer than that described for decellularized tissue ECMs from other organs ([@B10]). In concert with our findings, Pouliot and colleagues recently described decellularization and gelation of porcine lung using a pepsin digestion of 42 h ([@B22]). This difference in required digestion times may reflect the complexity of the lung matrix.

The measured stiffness of the control and IPF dECM hydrogels resembled the stiffness previously reported in the literature for whole and decellularized human lung samples in these categories ([@B3]). Prior rheological data available on the stiffness of COPD GOLD IV lungs in literature are limited ([@B16], [@B27]). Here, the average global stiffness of COPD GOLD IV tissue was similar to that of control lung tissue.

The dECM hydrogels relaxed completely after compression, whereas tissues did not, irrespective of the underlying disease. The relaxation behavior of a sample is dictated, in part, by the topical arrangement of ECM in intact tissue or degree and type (e.g., ionic or covalent) of internal cross-linking in hydrogels ([@B28], [@B30]). This may explain the higher degree of relaxation seen in the dECM hydrogels and the reduced degree of relaxation of IPF tissue compared with COPD GOLD IV and control tissue. The absence of cells in the dECM hydrogels would mean there were no new covalent cross-links established within the hydrogels. The greater degree of matrix organization in the IPF tissue ([@B26]) and the stiffer fibroblasts within these tissues ([@B14]) would also contribute to the differences in stress relaxation.

The total relaxation time was longer for lung tissue than for dECM hydrogels, with each Maxwell element contributing to the increased relaxation time. However, the patterns of relative contributions for all the elements were similar between tissue and ECM hydrogels, suggesting that the composition of the ECM in the hydrogels contributes to the relaxation capacity. Linking specific hydrogel components such as water, molecules, cells, or ECM to individual Maxwell elements remains difficult, such that currently these remain mathematical entities with no clear biological correlations as yet. However, in bacterial biofilms the constituent components were attributed to Maxwell elements with regard to their contributions to viscoelastic relaxation ([@B21]). For dECM hydrogels, the first element made the greatest contribution to the relaxation sequence, possibly reflecting the major role played by the water content of dECM hydrogels and absence of cell-derived or other tissue-related cross-links. In tissue each element contributed more equally to the relaxation process, except in IPF tissue. The 4th, slowest, element made the largest contribution to the relaxation in IPF tissue. Interestingly, all tissues and the IPF ECM hydrogel required 4 Maxwell element models to describe their relaxation, whereas control and COPD GOLD IV dECM hydrogels required 3, further suggesting that ECM composition also plays a role in viscoelasticity.

Some limitations of our experimental approach must be recognized. Proteoglycans and growth factors were lost or disrupted during the preparation procedure ([@B11], [@B18]), and the influence of these molecules on the rheological properties of the tissues/hydrogels is not known. The approach used here for measuring the rheology was at a macro (millimeter) scale. How these measurements compare to the nano scale of atomic force microscopy has yet to be examined. All the LLCT measurements were recorded at RT and thus may not fully reflect the biomechanical properties of the lung in vivo.

In conclusion, human lung dECM gels provide new opportunities for simulating the lung microenvironment, enabling the generation of novel models for mimicking native lung ECM in a research environment. Exciting opportunities now exist for exploring the response of human lung-derived cells in 3D environments through modulation of parameters including stiffness, dimensionality, protein content, and protein distribution for ECM from control, COPD GOLD IV, and IPF lungs.
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